Westport, CT, July 30, 2020 (GLOBE NEWSWIRE) --
Update on the PURE EP(tm) System installations and commercial progress
Update on Phase 2 clinical study of merimepodib in combination with remdesivir in adult patients with advanced COVID-19
BioSig Technologies, Inc. (Nasdaq: BSGM) (a??BioSiga?? or the a??Companya??), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that Kenneth L. Londoner, Chairman and CEO of BioSig Technologies, Inc. will present at the Proactive Investors One2One Virtual Event on August 4, 2020.
Event: Proactive Investors One2One Virtual Event
Date: Tuesday, August 4, 2020
Time: 1 PM ET
Registration link:
https://www.proactiveinvestors.com/register/event_details/269A For more information on the presentation please contact Andrew Ballou, Vice President, Investor Relations atA
aballou@biosigtech.com.About BioSig Technologies
BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals (
www.biosig.com).
